ES8405812A1 - Un procedimiento de preparacion de nuevos derivados diclorados de la serie 16- -metil-pregnano - Google Patents

Un procedimiento de preparacion de nuevos derivados diclorados de la serie 16- -metil-pregnano

Info

Publication number
ES8405812A1
ES8405812A1 ES526212A ES526212A ES8405812A1 ES 8405812 A1 ES8405812 A1 ES 8405812A1 ES 526212 A ES526212 A ES 526212A ES 526212 A ES526212 A ES 526212A ES 8405812 A1 ES8405812 A1 ES 8405812A1
Authority
ES
Spain
Prior art keywords
alpha
steroids
dicyclopentylmethoxy
cyclododecyloxy
suprising
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526212A
Other languages
English (en)
Other versions
ES526212A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of ES8405812A1 publication Critical patent/ES8405812A1/es
Publication of ES526212A0 publication Critical patent/ES526212A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/13Monohydroxylic alcohols containing saturated rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00Preparation of esters of carbonic or haloformic acids
    • C07C68/02Preparation of esters of carbonic or haloformic acids from phosgene or haloformates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE NUEVOS DERIVADOS DICLORADOS DE LA SERIE 16-BAB-METIL-PERGNANO.CO NSISTE EN PREPARAR LOS PRODUCTOS DE FORMULA (I) EN LA QUE R REPRESENTA UN RADICAL TRIMETILSILILFENILO, CICLODODECILOXI, DICICLOPENTILMETOXI O CICLOHEXILMETOXI. SE HACE REACCIONAR 9BAB,11-DICLORO-16-BAB-METIL-21-HIDROX IPREGNA-1,4-DIEN-3,20-DIONA CON UN PRODUCTO DE FORMULA (II), EN LA QUE HAL REPRESENTA UN ATOMO DE HALOGENO Y R TIENE EL SIGNIFICADO INDICADO ANTERIORMENTE, Y SE OBTIENE EL PRODUCTO ESPERADO. HAL REPRESENTA PREFERIBLEMENTE UN ATOMO DE CLORO O BROMO Y LA REACCION SE EFECTUA EN PRESENCIADE UN AGENTE BASICO COMO PIRIDINA O COLIDINA.TIENEN APLICACION FARMACOLOGICA ESPECIALMENTE COMO ANTI-INFLAMATORIA.
ES526212A 1982-10-05 1983-10-04 Un procedimiento de preparacion de nuevos derivados diclorados de la serie 16- -metil-pregnano Granted ES526212A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8216668A FR2533928A1 (fr) 1982-10-05 1982-10-05 Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
ES8405812A1 true ES8405812A1 (es) 1984-06-16
ES526212A0 ES526212A0 (es) 1984-06-16

Family

ID=9277977

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526212A Granted ES526212A0 (es) 1982-10-05 1983-10-04 Un procedimiento de preparacion de nuevos derivados diclorados de la serie 16- -metil-pregnano

Country Status (22)

Country Link
US (1) US4515787A (es)
JP (1) JPS59116300A (es)
AT (1) AT385996B (es)
AU (1) AU563739B2 (es)
BE (1) BE897906A (es)
CA (1) CA1203234A (es)
CH (1) CH659251A5 (es)
DE (1) DE3336292A1 (es)
DK (1) DK164062C (es)
ES (1) ES526212A0 (es)
FI (1) FI77668C (es)
FR (1) FR2533928A1 (es)
GB (1) GB2127827B (es)
HU (1) HU190506B (es)
IE (1) IE56022B1 (es)
IT (1) IT1197713B (es)
MA (1) MA19909A1 (es)
NL (1) NL8303409A (es)
NO (1) NO157864C (es)
OA (1) OA07558A (es)
SE (1) SE447388B (es)
ZA (1) ZA836538B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2561919B1 (fr) * 1984-04-03 1986-12-19 Roussel Uclaf Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon
GB8512738D0 (en) * 1984-09-04 1985-06-26 Gen Electric Silylation method
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
US7247607B2 (en) * 2001-11-08 2007-07-24 Green & Clean, Inc. Active soluble cleaning composite of natural state using soybean fatty acids and the making method thereof
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
FR2381065A2 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives halogenes de la serie du 16 a-methyl pregnane
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament

Also Published As

Publication number Publication date
AU563739B2 (en) 1987-07-23
FR2533928A1 (fr) 1984-04-06
GB2127827B (en) 1986-01-29
IE832337L (en) 1984-04-05
AT385996B (de) 1988-06-10
HU190506B (en) 1986-09-29
IT1197713B (it) 1988-12-06
FI77668B (fi) 1988-12-30
ES526212A0 (es) 1984-06-16
ZA836538B (en) 1984-10-31
NO832738L (no) 1984-04-06
ATA352783A (de) 1987-11-15
US4515787A (en) 1985-05-07
MA19909A1 (fr) 1984-04-01
SE447388B (sv) 1986-11-10
AU1982483A (en) 1984-04-12
BE897906A (fr) 1984-04-04
GB2127827A (en) 1984-04-18
SE8304062L (sv) 1984-04-06
FR2533928B1 (es) 1985-05-03
FI77668C (fi) 1989-04-10
JPH0412279B2 (es) 1992-03-04
NL8303409A (nl) 1984-05-01
DK164062B (da) 1992-05-04
DK456483D0 (da) 1983-10-04
JPS59116300A (ja) 1984-07-05
DE3336292A1 (de) 1984-04-05
OA07558A (fr) 1985-03-31
SE8304062D0 (sv) 1983-07-20
GB8326527D0 (en) 1983-11-02
NO157864C (no) 1988-06-01
DK164062C (da) 1992-09-28
DE3336292C2 (es) 1992-09-10
NO157864B (no) 1988-02-22
FI833602A (fi) 1984-04-06
FI833602A0 (fi) 1983-10-04
CH659251A5 (fr) 1987-01-15
CA1203234A (fr) 1986-04-15
IE56022B1 (en) 1991-03-27
DK456483A (da) 1984-04-06

Similar Documents

Publication Publication Date Title
AU529097B2 (en) Two stage gasification of fine grained solid fuels
AU520727B2 (en) Solid additives in form of aggregates of fine particles
AU8346082A (en) Methods and compositions for intravaginal contraception
DE3172829D1 (en) Process for the production of fuel compositions and fuel compositions thereby produced
ES8502709A1 (es) Procedimiento para la preparacion de 1-alquil-androsta-1,4-dien-3,17-dionas
ES8405812A1 (es) Un procedimiento de preparacion de nuevos derivados diclorados de la serie 16- -metil-pregnano
AU527592B2 (en) 3,20-dioxo-4,9-diene-21-hydroxyl steroid derivatives
IE802379L (en) Prednisolone diesters
AU7602781A (en) Compositions of anti-inflammatory steroids
DE3267355D1 (en) Process for the preparation of delta 9(11)- and delta 16-21-chloro-20-keto steroids of the pregnane and d-homopregnane series and their use as intermediates for the synthesis of highly effective corticoids
ES8405421A1 (es) Procedimiento para la preparacion de nuevos 6 -metilcorticoides
AU521011B2 (en) 1,3-dibenzoic acid esters of 17alpha-ethynyl-7alpha-methyl- delta1,3,5,(10) -oestratriene-1,3,17beta-triol and their manufacture and use
AU519158B2 (en) Gasification of pellelized fuel
IE42168L (en) 1-alpha-hydroxy and alkanoyloxy-steroids
GB1532046A (en) Glass
GB2037747B (en) Preparation of n-phenyl-n'-alkylphenylenediamines
ZA851927B (en) Pharmaceutical composition containing 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy preggna-1,4-diene-3,20-dione
IL56494A (en) 17 alpha-alkoxyalkoxy steroids of the pregnane series,their preparation and pharmaceutical compositions containing them
NZ184142A (en) Antibiotics of a-35512 group from culturing streptomyces candidus nrrl 8156
ES467886A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico.
GB1460163A (en) Purification of 6,7-methylene steroid lactones
EP0124252A3 (en) Double ester of 16beta-ethylestran-17beta-ol derivatives
ES485784A1 (es) Procedimiento para la obtencion de esteres de hidrocortisona
ES485785A1 (es) Procedimiento para la obtencion de ortoesteres de hidrocor- tisona
ES8507155A3 (es) Metodo para la obtencion de esteroides de la serie de prednisolona

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519